Clinical Trials List
Protocol NumberCLTW888A12401
Active
2023-12-01 - 2032-12-31
Phase IV
Recruiting1
ICD-10H35.50
Unspecified hereditary retinal dystrophy
ICD-9362.70
Hereditary retinal dystrophy unspecified
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- CHUNG-MAY YANG Division of Ophthalmology
- CHANG-HAO YANG Division of Ophthalmology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
接受本品治療之病人 participants
-
Global
40 participants
